Kang HG - Search Results

1

Post-translational modification of OCT4 in breast cancer tumorigenesis.

Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH. Cho Y, et al. Among authors: kang mj, kang hg. Cell Death Differ. 2018 Nov;25(10):1781-1795. doi: 10.1038/s41418-018-0079-6. Epub 2018 Mar 6. Cell Death Differ. 2018. PMID: 29511337 Free PMC article.

2

Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer.

Kim SJ, Wang YG, Lee HW, Kang HG, La SH, Choi IJ, Irimura T, Ro JY, Bresalier RS, Chun KH. Kim SJ, et al. Among authors: kang hg. Oncotarget. 2014 May 30;5(10):3386-98. doi: 10.18632/oncotarget.1960. Oncotarget. 2014. PMID: 24930499 Free PMC article.

3

Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity.

Baek JH, Kim SJ, Kang HG, Lee HW, Kim JH, Hwang KA, Song J, Chun KH. Baek JH, et al. Among authors: kang hg. Endocrinology. 2015 Jan;156(1):147-56. doi: 10.1210/en.2014-1374. Endocrinology. 2015. PMID: 25343273

4

Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance.

Park EY, Chang E, Lee EJ, Lee HW, Kang HG, Chun KH, Woo YM, Kong HK, Ko JY, Suzuki H, Song E, Park JH. Park EY, et al. Among authors: kang hg. Cancer Res. 2014 Dec 15;74(24):7573-82. doi: 10.1158/0008-5472.CAN-14-1140. Epub 2014 Nov 3. Cancer Res. 2014. PMID: 25368020

5

Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.

Cho Y, Lee HW, Kang HG, Kim HY, Kim SJ, Chun KH. Cho Y, et al. Among authors: kang hg. Oncotarget. 2015 Apr 20;6(11):8709-21. doi: 10.18632/oncotarget.3325. Oncotarget. 2015. PMID: 25909162 Free PMC article.

6

A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.

Kim do Y, Park EY, Chang E, Kang HG, Koo Y, Lee EJ, Ko JY, Kong HK, Chun KH, Park JH. Kim do Y, et al. Among authors: kang hg. Oncotarget. 2016 Mar 22;7(12):14791-802. doi: 10.18632/oncotarget.7443. Oncotarget. 2016. PMID: 26895471 Free PMC article.

7

Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1.

Ann EJ, Kim MY, Yoon JH, Ahn JS, Jo EH, Lee HJ, Lee HW, Kang HG, Choi DW, Chun KH, Lee JS, Choi CY, Ferrando AA, Lee K, Park HS. Ann EJ, et al. Among authors: kang hg. Cancer Res. 2016 Aug 15;76(16):4728-40. doi: 10.1158/0008-5472.CAN-15-3310. Epub 2016 Jun 22. Cancer Res. 2016. PMID: 27335110

8

Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer.

Kim HY, Cho Y, Kang H, Yim YS, Kim SJ, Song J, Chun KH. Kim HY, et al. Oncotarget. 2016 Aug 2;7(31):49902-49916. doi: 10.18632/oncotarget.10231. Oncotarget. 2016. PMID: 27363019 Free PMC article.

9

Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma.

Kong HK, Park SJ, Kim YS, Kim KM, Lee HW, Kang HG, Woo YM, Park EY, Ko JY, Suzuki H, Chun KH, Song E, Jang KY, Park JH. Kong HK, et al. Among authors: kang hg. Oncotarget. 2016 Aug 23;7(34):55677-55689. doi: 10.18632/oncotarget.10972. Oncotarget. 2016. PMID: 27494879 Free PMC article.

10

Ablation of human telomerase reverse transcriptase (hTERT) induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism.

La SH, Kim SJ, Kang HG, Lee HW, Chun KH. La SH, et al. Among authors: kang hg. Oncotarget. 2016 Aug 30;7(35):57117-57130. doi: 10.18632/oncotarget.10986. Oncotarget. 2016. PMID: 27494887 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

945 results

Search Page

Filters